![Juergen Lasowski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Juergen Lasowski
Entité | Type d'entité | Industrie | |
---|---|---|---|
Aventis Pharmaceuticals, Inc.
![]() Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ.
34
| Subsidiary | Pharmaceuticals: Major | 34 |
Hoechst Marion Roussel, Inc.
20
| Subsidiary | 20 | |
Subsidiary | Pharmaceuticals: Major | 15 | |
Sanofi-Aventis U.S. LLC
![]() Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Juergen Lasowski via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Wyeth Corp.
![]() Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
CELGENE | Biotechnology | Chief Executive Officer Sales & Marketing | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Sales & Marketing Sales & Marketing | |
Oscient Pharmaceuticals Corp.
![]() Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | President Sales & Marketing | |
ARIAD PHARMACEUTICALS, INC. | Biotechnology | President Director/Board Member | |
IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
TENAX THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member Chief Operating Officer | |
Shire ViroPharma, Inc.
![]() Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
HMR Pharma, Inc. | Sales & Marketing Comptroller/Controller/Auditor | ||
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Director/Board Member | |
THE MEDICINES COMPANY | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Santarus, Inc.
![]() Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Executive Officer Sales & Marketing | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Aventis, Inc. | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
SINTX TECHNOLOGIES, INC. | Medical Specialties | Compliance Officer Chief Operating Officer Comptroller/Controller/Auditor | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
University of Pennsylvania | College/University | Doctorate Degree Masters Business Admin Masters Business Admin | |
Rockhurst University | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
University of Utah | College/University | Doctorate Degree Undergraduate Degree | |
Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Undergraduate Degree | |
Yale University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
St. John's University | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
St. Joseph's University | College/University | Undergraduate Degree Undergraduate Degree Director/Board Member | |
University of Tennessee | College/University | Masters Business Admin Masters Business Admin | |
NEPHROGENEX INC | Medical Distributors | Chief Executive Officer Director/Board Member | |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal President | |
NS WIND DOWN CO., INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Université de Technologie de Compiègne | College/University | Doctorate Degree Doctorate Degree | |
HEC Montréal | College/University | Undergraduate Degree Undergraduate Degree | |
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member | |
Massachusetts Biotechnology Council
![]() Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
University of Missouri-Kansas City | College/University | Corporate Officer/Principal Doctorate Degree | |
Phyxius Pharma, Inc.
![]() Phyxius Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Tenax Therapeutics, Inc., Phyxius Pharma, Inc. provides pharmaceutical products. The company is based in Chester, NJ. The company was founded by Doug Randall, Douglas Hay, John P. Kelley. Phyxius Pharma was acquired by Life Newco, Inc. on November 13, 2013 for $32.66 million. | Pharmaceuticals: Major | Founder Founder | |
Sanofi-Aventis Groupe SA
![]() Sanofi-Aventis Groupe SA Financial ConglomeratesFinance Sanofi-Aventis Groupe SA operates as a holding company, with interest in the manufacture and distribution of pharmaceutical products. The company was founded on December 19, 1995 and is headquartered in Paris, France. | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal | |
Navigen, Inc.
![]() Navigen, Inc. Pharmaceuticals: MajorHealth Technology Navigen, Inc. operates as a drug discovery and development company. The company was founded by Hunter Jackson and is headquartered in Salt Lake City, UT. | Pharmaceuticals: Major | Founder Director/Board Member Comptroller/Controller/Auditor | |
CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Visgenx, Inc.
![]() Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | Biotechnology | Founder Director/Board Member |
Statistiques
Internationale
Etats-Unis | 43 |
France | 6 |
Canada | 3 |
Suisse | 2 |
Sectorielle
Health Technology | 30 |
Consumer Services | 11 |
Commercial Services | 4 |
Finance | 4 |
Distribution Services | 3 |
Opérationnelle
Director/Board Member | 276 |
Corporate Officer/Principal | 228 |
Independent Dir/Board Member | 71 |
Chief Executive Officer | 67 |
Chief Tech/Sci/R&D Officer | 66 |
Relations les plus connectées
Insiders | |
---|---|
Pierre Legault | 45 |
Norbert Riedel | 29 |
Frank Douglas | 29 |
Santo Costa | 28 |
Francois Nader | 28 |
Mitchell Finer | 26 |
Joseph Klein | 24 |
Errol de Souza | 21 |
John Leone | 21 |
Mark Alles | 20 |
Brian O'Callaghan | 20 |
Troy Cox | 19 |
Gerry Proehl | 19 |
Martin Zeiger | 19 |
Jack Dean | 17 |
- Bourse
- Insiders
- Juergen Lasowski
- Connexions Sociétés